trending Market Intelligence /marketintelligence/en/news-insights/trending/pl6gtattyfld7rd-saep3w2 content esgSubNav
In This List

GeoVax names CEO

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


GeoVax names CEO

Smyrna, Ga.-based GeoVax Labs Inc., a clinical-stage biotechnology company, appointed David Dodd as president and CEO, effective Sept. 1.

Dodd succeeds Robert McNally, who has retired but will remain a director of the company.

Dodd became a board member of the company in March 2010 and was elected chairman in January 2011. He served as CEO and director of Medizone International Inc., a medical device manufacturer, from September 2017 to June 2018.